CNBX PHARMACEUTICALS INC. Cash and Restricted Cash
CNBX PHARMACEUTICALS INC. (CNBX) had Cash and Restricted Cash of $9.49 thousand as of 2026-05-31, per its 10-Q filed 2026-06-24.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-06-24
- 2026-05-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $9.49K.
- 2026-02-28: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $12.15K.
- 2025-11-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.70K.
- 2025-08-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15.11K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-05-31 | $9.49K 10-Q · filed 2026-06-24 | |
| 2026-02-28 | $12.15K 10-Q · filed 2026-04-14 | |
| 2025-11-30 | $7.70K 10-Q · filed 2026-01-14 | |
| 2025-08-31 | $15.11K 10-Q · filed 2026-06-24 | |
| 2025-05-31 | $13.65K 10-Q · filed 2026-06-24 | |
| 2025-02-28 | $45.67K 10-Q · filed 2026-04-14 | |
| 2024-11-30 | $17.34K 10-Q · filed 2026-01-14 | |
| 2024-08-31 | $26.42K 10-Q · filed 2026-06-24 | |
| 2024-05-31 | $73.41K 10-Q · filed 2025-07-14 | |
| 2024-02-29 | $37.14K 10-Q · filed 2025-04-14 | |
| 2023-11-30 | $81.65K 10-Q · filed 2025-01-13 | |
| 2023-08-31 | $129.70K 10-K · filed 2025-12-01 | |
| 2023-05-31 | $44.15K 10-Q · filed 2024-07-15 | |
| 2023-02-28 | $47.75K 10-Q · filed 2024-04-16 | |
| 2022-11-30 | $21.60K 10-Q · filed 2024-01-12 | |
| 2022-08-31 | $117.52K 10-K · filed 2024-11-29 | |
| 2022-05-31 | $96.28K 10-Q · filed 2023-07-14 | |
| 2022-02-28 | $231.64K 10-Q · filed 2023-04-14 | |
| 2021-11-30 | $786.41K 10-Q · filed 2023-01-13 | |
| 2021-08-31 | $1.39M 10-K · filed 2023-11-30 | $1.39M 10-Q · filed 2022-04-12 |
| 2021-05-31 | $1.99M 10-Q · filed 2022-07-14 | |
| 2021-02-28 | $1.33M 10-Q · filed 2022-04-12 | |
| 2020-08-31 | $777.61K 10-K · filed 2022-11-30 |